TALEN

TALEN1-adgrg6

ID

ZDB-TALEN-150413-1

Name

TALEN1-adgrg6

Previous Names

None

Target

Target Sequence 1

5' - TCTGCTTGTGTAATCACCTCA - 3'

Target Sequence 2

5' - TCCCACAAATCTCACCATTA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
stl215	adgrg6

Expression

Gene expression in Wild Types + TALEN1-adgrg6

No data available

Phenotype

Phenotype resulting from TALEN1-adgrg6

No data available

Phenotype of all Fish created by or utilizing TALEN1-adgrg6

Phenotype	Fish	Conditions	Figures
posterior lateral line nerve mbpa expression amount, ameliorated	adgrg6^{stl215/stl215}	chemical treatment by environment: telmisartan	Fig. 3 from Bradley et al., 2019
posterior lateral line nerve mbpa expression amount, ameliorated	adgrg6^{stl215/stl215}	chemical treatment by environment: undecenoic acid	Fig. 3 from Bradley et al., 2019
posterior lateral line nerve mbpa expression amount, ameliorated	adgrg6^{stl215/stl215}	chemical treatment by environment: apomorphine hydrochloride	Fig. 4 from Bradley et al., 2019
posterior lateral line nerve mbpa expression amount, ameliorated	adgrg6^{stl215/stl215}	chemical treatment by environment: naloxone hydrochloride	Fig. 3 from Bradley et al., 2019
inner ear swollen, abnormal	adgrg6^{stl215/stl215}	standard conditions	Fig. 4 from Liebscher et al., 2014
posterior lateral line nerve myelination in peripheral nervous system decreased process quality, abnormal	adgrg6^{stl215/stl215}	standard conditions	Fig. S3 from Liebscher et al., 2014
posterior lateral line nerve mbpa expression absent, abnormal	adgrg6^{stl215/stl215}	control	Fig. 3, Fig. 4 from Bradley et al., 2019

Citations